Intermediate Reports
Press Releases

Novolog to Report 2021 Full Year and Fourth Quarter Results and Host Conference Call on 14.3.22

,
March 9, 2022
May 8, 2022

Novolog (Pharm-Up 1966) Ltd. is honored to announce that its financial statements for 2021 will be published on Monday, March 14, 2022, on the distribution website of the Securities Authority at www.magna.isa.gov.il, and on the Tel Aviv Stock Exchange website at www.maya.tase.co.il.

Following the publication of the financial statements, the Company will hold a conference call to review the Company's financial statements for 2021, on Monday, March 14, 2022 at 11:00 AM using the ZOOM app. To join the call you can use the following link: https://us02web.zoom.us/j/86394922322

The conference call does not replace the need to review the Company's financial statements and the Board of Directors' Report as of December 31, 2021, as well as the immediate reports and presentations published by the Company from time to time, including full forward-looking information in accordance with section 32A of the Securities Law, 1968.

Press Releases

June 30, 2024
March 6, 2024

The publication date for the financial statements of 2023 is March 26th, 2024, with a conference meeting scheduled for the same date at 1:00 PM

April 19, 2023
April 18, 2023

Eran Taus, the CEO of Novolog, has announced that he will be stepping down from his position after six years

March 10, 2022
December 21, 2021

Preliminary medical inquiries, without human contact

Novolog Group’s Digital Division, together with the startup Kahun, are currently launching “Symptomi”

Intermediate Reports

October 1, 2025
September 30, 2025

Company's Extraordinary and Annual General Meeting of Shareholders will be held on Tuesday, November 4, 2025

January 28, 2025
January 19, 2025

Update regarding the launching of a new ERP system

January 8, 2025
November 19, 2024

In November 19, 2024, the company announced distribution of dividend in the amount of NIS 10 million